Chapter/Section Purchase

1 Study Coverage
1.1 Malaria Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Malaria Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pre-Erythrocytic Vaccine
1.2.3 Erythrocytic Vaccine
1.2.4 Multi-antigen Vaccine
1.3 Market by Application
1.3.1 Global Malaria Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Community Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Malaria Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Malaria Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Malaria Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Malaria Vaccines Sales by Region
2.4.1 Global Malaria Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Malaria Vaccines by Region (2023-2028)
2.5 Global Malaria Vaccines Revenue by Region
2.5.1 Global Malaria Vaccines Revenue by Region (2017-2022)
2.5.2 Global Malaria Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Malaria Vaccines Sales by Manufacturers
3.1.1 Global Top Malaria Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Malaria Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Malaria Vaccines in 2021
3.2 Global Malaria Vaccines Revenue by Manufacturers
3.2.1 Global Malaria Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Malaria Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Malaria Vaccines Revenue in 2021
3.3 Global Malaria Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Malaria Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Malaria Vaccines Sales by Type
4.1.1 Global Malaria Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Malaria Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Malaria Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Malaria Vaccines Revenue by Type
4.2.1 Global Malaria Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Malaria Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Malaria Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Malaria Vaccines Price by Type
4.3.1 Global Malaria Vaccines Price by Type (2017-2022)
4.3.2 Global Malaria Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Malaria Vaccines Sales by Application
5.1.1 Global Malaria Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Malaria Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Malaria Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Malaria Vaccines Revenue by Application
5.2.1 Global Malaria Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Malaria Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Malaria Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Malaria Vaccines Price by Application
5.3.1 Global Malaria Vaccines Price by Application (2017-2022)
5.3.2 Global Malaria Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Malaria Vaccines Market Size by Type
6.1.1 North America Malaria Vaccines Sales by Type (2017-2028)
6.1.2 North America Malaria Vaccines Revenue by Type (2017-2028)
6.2 North America Malaria Vaccines Market Size by Application
6.2.1 North America Malaria Vaccines Sales by Application (2017-2028)
6.2.2 North America Malaria Vaccines Revenue by Application (2017-2028)
6.3 North America Malaria Vaccines Market Size by Country
6.3.1 North America Malaria Vaccines Sales by Country (2017-2028)
6.3.2 North America Malaria Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Malaria Vaccines Market Size by Type
7.1.1 Europe Malaria Vaccines Sales by Type (2017-2028)
7.1.2 Europe Malaria Vaccines Revenue by Type (2017-2028)
7.2 Europe Malaria Vaccines Market Size by Application
7.2.1 Europe Malaria Vaccines Sales by Application (2017-2028)
7.2.2 Europe Malaria Vaccines Revenue by Application (2017-2028)
7.3 Europe Malaria Vaccines Market Size by Country
7.3.1 Europe Malaria Vaccines Sales by Country (2017-2028)
7.3.2 Europe Malaria Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Malaria Vaccines Market Size by Type
8.1.1 Asia Pacific Malaria Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Malaria Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Malaria Vaccines Market Size by Application
8.2.1 Asia Pacific Malaria Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Malaria Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Malaria Vaccines Market Size by Region
8.3.1 Asia Pacific Malaria Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Malaria Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Malaria Vaccines Market Size by Type
9.1.1 Latin America Malaria Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Malaria Vaccines Revenue by Type (2017-2028)
9.2 Latin America Malaria Vaccines Market Size by Application
9.2.1 Latin America Malaria Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Malaria Vaccines Revenue by Application (2017-2028)
9.3 Latin America Malaria Vaccines Market Size by Country
9.3.1 Latin America Malaria Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Malaria Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Malaria Vaccines Market Size by Type
10.1.1 Middle East and Africa Malaria Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Malaria Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Malaria Vaccines Market Size by Application
10.2.1 Middle East and Africa Malaria Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Malaria Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Malaria Vaccines Market Size by Country
10.3.1 Middle East and Africa Malaria Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Malaria Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Corporation Information
11.1.2 GlaxoSmithKline Plc Overview
11.1.3 GlaxoSmithKline Plc Malaria Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Plc Malaria Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Plc Recent Developments
11.2 Sanaria Inc
11.2.1 Sanaria Inc Corporation Information
11.2.2 Sanaria Inc Overview
11.2.3 Sanaria Inc Malaria Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanaria Inc Malaria Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanaria Inc Recent Developments
11.3 Nobelpharma Co
11.3.1 Nobelpharma Co Corporation Information
11.3.2 Nobelpharma Co Overview
11.3.3 Nobelpharma Co Malaria Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nobelpharma Co Malaria Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nobelpharma Co Recent Developments
11.4 Sumaya Biotech
11.4.1 Sumaya Biotech Corporation Information
11.4.2 Sumaya Biotech Overview
11.4.3 Sumaya Biotech Malaria Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sumaya Biotech Malaria Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sumaya Biotech Recent Developments
11.5 GenVec
11.5.1 GenVec Corporation Information
11.5.2 GenVec Overview
11.5.3 GenVec Malaria Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GenVec Malaria Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GenVec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Malaria Vaccines Industry Chain Analysis
12.2 Malaria Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Malaria Vaccines Production Mode & Process
12.4 Malaria Vaccines Sales and Marketing
12.4.1 Malaria Vaccines Sales Channels
12.4.2 Malaria Vaccines Distributors
12.5 Malaria Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Malaria Vaccines Industry Trends
13.2 Malaria Vaccines Market Drivers
13.3 Malaria Vaccines Market Challenges
13.4 Malaria Vaccines Market Restraints
14 Key Findings in The Global Malaria Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer